Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by TJ Schnitzer
SAT0548 Plasma CGRP Concentrations Were Not Associated With Patient OA Symptoms or Response to Galcanezumab, a Monoclonal Antibody Against CGRP
Related publications
In Vitro Characterization of AA71, a Potent and Selective Human Monoclonal Antibody Against CGRP Receptor
Journal of Headache and Pain
Medicine
Neurology
Anesthesiology
Pain Medicine
Galcanezumab: A Monoclonal Antibody for Migraine Prophylaxis
Prescriber
Pharmacology
Cervicogenic Headache Responsive to Galcanezumab in Patients With Comorbid Migraine: A Case Series. Running Head: CH and Migraine Responsive to CGRP Abs
New Trends in Migraine Pharmacology: Targeting Calcitonin Gene–Related Peptide (CGRP) With Monoclonal Antibodies
Frontiers in Pharmacology
Pharmacology
Approvals and Indications of CGRP Antibodies
The Lancet Neurology
Neurology
Targeting CGRP: A New Era for Migraine Treatment
CNS Drugs
Psychiatry
Mental Health
Neurology
Pharmacology
Calcitonin Gene-Related Peptide (CGRP; CALCA)
Science-Business eXchange
CGRP as a Migraine Inducing Substance
The Scientific World Journal
Biochemistry
Medicine
Genetics
Molecular Biology
Environmental Science
Neuropeptide CGRP Regulates Inflammation by Increasing Lymphangiogenesis
Proceedings for Annual Meeting of The Japanese Pharmacological Society